2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2024-10-3-0-53506Genetics<strong>Geno-phenotypic features of cystic fibrosis in Russian children from the Chechen and Karachay-Cherkess Republics</strong><strong>Geno-phenotypic features of cystic fibrosis in Russian children from the Chechen and Karachay-Cherkess Republics</strong>SimonovMaxim V.SimonovMaxim V.drsimonov@vk.comGorinovaYulia V.GorinovaYulia V.ygorinova@yandex.ruSimonovaOlga I.SimonovaOlga I.oisimonova@mail.ruPushkovAlexander A.PushkovAlexander A.pushkovgenetika@gmail.comZhaninIlya S.ZhaninIlya S.ilya_zhanin@outlook.comAlekseevaAlina Y.AlekseevaAlina Y.alinalaboratoria@gmail.comDemyanovDmitry S.DemyanovDmitry S.ilya_zhanin@outlook.comAsanovAliy Y.AsanovAliy Y.aliy@rambler.ruSavostyanovKirill V.SavostyanovKirill V.7443333@gmail.com202410300

Background: Cystic fibrosis (CF) is an autosomal recessive disease that occurs with a frequency of 1:1,500 to 1:5,000 newborns, according to the World Health Organization. In the Russian Federation, the average incidence of the disease is 1:10,000 newborns. The medical and social significance of this disease is associated with the early disability of patients, the need for long-term treatment and constant follow-up, as well as the heterogeneity of phenotypic manifestations, which in turn requires early diagnosis using molecular genetic methods. The aim of the study: To study the clinical and molecular genetic characteristics of children with CF from the Chechen and Karachay-Cherkess Republics. Materials and methods: The study included 237 patients with a confirmed diagnosis of CF. Molecular genetic diagnostics was performed using the method of mass parallel sequencing using a hybridization target panel that includes the entire CFTR gene. Sequencing was performed on the MiSeq platform. All causal nucleotide variants were validated using Sanger sequencing. Results: The most common amino acid variants of the CFTR gene in patients with CF from the Chechen Republic are: p.Y515* (94 alleles/78.3%), p.E92K (18 alleles/15%). The presence of variants p.Y515* and p.E92K in the heterozygous state in the genotype is more often a favorable prognostic factor for the absence of pancreatic lesion. The main distinctive clinical feature of these patients is the onset of the disease with manifestations of pseudo-Bartter syndrome. The major amino acid variant of the CFTR gene in patients with CF from the Karachay-Cherkess Republic is: p.W1282* (28 alleles/70%). The number of patients with pseudo-Bartter syndrome was 54.5%. In 90% of cases, in patients who are homo- and heterozygous according to p.W1282*, a severe degree of pancreatic insufficiency was noted. Conclusion: Patients with cystic fibrosis from the Chechen and Karachay-Cherkess Republics are a difficult category of patients, despite neonatal screening, and cystic fibrosis therapy developed and implemented.&nbsp; This is partly due to the peculiarities of the phenotype and the unique distribution of alleles and genotypes of the CFTR gene. The high number of homozygous variants of the CFTR gene in patients from the Chechen and Karachay-Cherkess Republics is probably due to monoethnic marital assortativity

Background: Cystic fibrosis (CF) is an autosomal recessive disease that occurs with a frequency of 1:1,500 to 1:5,000 newborns, according to the World Health Organization. In the Russian Federation, the average incidence of the disease is 1:10,000 newborns. The medical and social significance of this disease is associated with the early disability of patients, the need for long-term treatment and constant follow-up, as well as the heterogeneity of phenotypic manifestations, which in turn requires early diagnosis using molecular genetic methods. The aim of the study: To study the clinical and molecular genetic characteristics of children with CF from the Chechen and Karachay-Cherkess Republics. Materials and methods: The study included 237 patients with a confirmed diagnosis of CF. Molecular genetic diagnostics was performed using the method of mass parallel sequencing using a hybridization target panel that includes the entire CFTR gene. Sequencing was performed on the MiSeq platform. All causal nucleotide variants were validated using Sanger sequencing. Results: The most common amino acid variants of the CFTR gene in patients with CF from the Chechen Republic are: p.Y515* (94 alleles/78.3%), p.E92K (18 alleles/15%). The presence of variants p.Y515* and p.E92K in the heterozygous state in the genotype is more often a favorable prognostic factor for the absence of pancreatic lesion. The main distinctive clinical feature of these patients is the onset of the disease with manifestations of pseudo-Bartter syndrome. The major amino acid variant of the CFTR gene in patients with CF from the Karachay-Cherkess Republic is: p.W1282* (28 alleles/70%). The number of patients with pseudo-Bartter syndrome was 54.5%. In 90% of cases, in patients who are homo- and heterozygous according to p.W1282*, a severe degree of pancreatic insufficiency was noted. Conclusion: Patients with cystic fibrosis from the Chechen and Karachay-Cherkess Republics are a difficult category of patients, despite neonatal screening, and cystic fibrosis therapy developed and implemented.&nbsp; This is partly due to the peculiarities of the phenotype and the unique distribution of alleles and genotypes of the CFTR gene. The high number of homozygous variants of the CFTR gene in patients from the Chechen and Karachay-Cherkess Republics is probably due to monoethnic marital assortativity

cystic fibrosisCFTR geneChechen RepublicKarachay-Cherkess Republicphenotypegenotypecorrelationsmass parallel sequencingpseudo-Bartter syndromecystic fibrosisCFTR geneChechen RepublicKarachay-Cherkess Republicphenotypegenotypecorrelationsmass parallel sequencingpseudo-Bartter syndromeСписок литературыDickinson KM, Collaco JM. Cystic Fibrosis. Pediatrics in Review. 2021;42(2):55-67. DOI: https://doi.org/10.1542/pir.2019-0212Elborn JS. Cystic fibrosis. The Lancet. 2016;388(10059):2519-2531. DOI: https://doi.org/10.1016/S0140-6736(16)00576-6Kashirskaya NU, Kapranov NI, Kondratieva EI, editors. Cystic fibrosis. 2nd edition, revised and enlarged. Moscow: ID &quot;MEDPRAKTIKA-M&quot;; 2021. Russian.National Center for biotechnology information [Электронный ресурс] [дата обращения 27.11.2023]. URL: https://ncbi.nlm.nih.gov/snp/?term=CFTRMarson FAL, Bertuzzo CS, Ribeiro JD. Classification of CFTR mutation classes. The Lancet Respiratory Medicine. 2016;4(8):e37-e38. DOI: https://doi.org/10.1016/S2213-2600(16)30188-6De Boeck K, Amaral MD. Progress in therapies for cystic fibrosis. The Lancet Respiratory Medicine. 2016;4(8):662-674. DOI: https://doi.org/10.1016/S2213-2600(16)00023-0Castellani C, Cuppens H, Macek M, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. Journal of Cystic Fibrosis. 2008;7(3):179-196. DOI: https://doi.org/10.1016/j.jcf.2008.03.009Sosnay PR, Siklosi KR, Van Goor F, et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nature Genetics. 2013;45(10):1160-1167. DOI: https://doi.org/10.1038/ng.2745Gorinova UV, Savostyanov KV, Pushkov AA, et al. Genotype-phenotypic correlations of the course of cystic fibrosis in Russian children. The first description of eleven new mutations. Issues of modern pediatrics. 2018;17(1):61-69.&nbsp; Russian. DOI: https://doi.org/10.15690/vsp.v17i1.1856Baranov AA, Kapranov NI, Kashirskaya NYu, et al. Diagnostic problems of mucoviscidosis and ways of solution in Russia. Pediatric pharmacology. 2014;11(6):16-23. Russian. DOI: https://doi.org/10.15690/pf.v11i6.1211Bonyadi M, Omrani O, Rafeey M, et al. Spectrum of CFTR gene mutations in Iranian Azeri Turkish patients with cystic fibrosis. Genetic Testing and Molecular Biomarkers. 2011;15(1-2):89-92. DOI: https://doi.org/10.1089/gtmb.2010.0091Lopes-Pacheco M, Boinot C, Sabirzhanova I, et al. Combination of Correctors Rescues CFTR Transmembrane-Domain Mutants by Mitigating their Interactions with Proteostasis. Cellular Physiology and Biochemistry. 2017;41(6):2194-2210. DOI: https://doi.org/10.1159/000475578Ivanov M, Matsvay A, Glazova O, et al. Targeted sequencing reveals complex, phenotype-correlated genotypes in cystic fibrosis. BMC Medical Genomics. 2018;11:13. DOI: https://doi.org/10.1186/s12920-018-0328-zPetrova NV, Kashirskaya NY, Saydaeva DK, et al. Spectrum of CFTR mutations in Chechen cystic fibrosis patients: high frequency of c.1545_1546delTA (p.Tyr515X; 1677delTA) and c.274G&gt;A (p.Glu92Lys, E92K) mutations in North Caucasus. BMC Medical Genetics. 2019;20(1):44. DOI: https://doi.org/10.1186/s12881-019-0785-zCui G, Rahman KS, Infield DT, et al. Three charged amino acids in extracellular loop 1 are involved in maintaining the outer pore architecture of CFTR. Journal of General Physiology. 2014;144(2):159-179. DOI: https://doi.org/10.1085/jgp.201311122Peabody Lever JE, Mutyam V, Hathorne HY, et al. Ataluren/ivacaftor combination therapy: Two N-of-1 trials in cystic fibrosis patients with nonsense mutations. Pediatric Pulmonology. 2020;55(7):1838-1842. DOI: https://doi.org/10.1002/ppul.24764Petrova NV, Kashirskaya NY, Vasilyeva TA, et al. Analysis of&nbsp;CFTR&nbsp;Mutation Spectrum in Ethnic Russian Cystic Fibrosis Patients. Genes. 2020;11(5):554. DOI: https://doi.org/10.3390/genes11050554Lundman E, Gaup HJ, Bakkeheim E, et al. Implementation of newborn screening for cystic fibrosis in Norway. Results from the first three years. Journal of Cystic Fibrosis. 2016;15(3):318-324. DOI: https://doi.org/10.1016/j.jcf.2015.12.017S&aacute;nchez K, de Mendonca E, Matute X, et al. Analysis of the CFTR gene in Venezuelan cystic fibrosis patients, identification of six novel cystic fibrosis-causing genetic variants. Application of Clinical Genetics. 2016;9:33-38. DOI: https://doi.org/10.2147/TACG.S78241Terlizzi V, Amato F, Castellani C, et al. Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype. Molecular genetics &amp; genomic medicine. 2021;9(4):e1656. DOI: https://doi.org/10.1002/mgg3.1656Martins RDS, Campos Junior M, Dos Santos Moreira A, et al. Identification of a novel large deletion and other copy number variations in the CFTR gene in patients with Cystic Fibrosis from a multiethnic population. Molecular genetics &amp; genomic medicine. 2019;7(7):e00645. DOI: https://doi.org/10.1002/mgg3.645Lucarelli M, Bruno SM, Pierandrei S, et al. A Genotypic-Oriented View of CFTR Genetics Highlights Specific Mutational Patterns Underlying Clinical Macrocategories of Cystic Fibrosis. Molecular Medicine. 2015;21(1):257-275. DOI: https://doi.org/10.2119/molmed.2014.00229Claustres M, Th&egrave;ze C, des Georges M, et al. CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variants. Human Mutation. 2017;38(10):1297-1315. DOI: https://doi.org/10.1002/humu.23276Hirtz S, Gonska T, Seydewitz HH, et al. CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis. Gastroenterology. 2004;127(4):1085-1095. DOI: https://doi.org/10.1053/j.gastro.2004.07.006Lakeman P, Gille JJ, Dankert-Roelse JE, et al. CFTR mutations in Turkish and North African cystic fibrosis patients in Europe: implications for screening. Genetic Testing. 2008;12(1):25-35. DOI: https://doi.org/10.1089/gte.2007.0046Joynt AT, Evans TA, Pellicore MJ, et al. Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies. PLoS Genetics. 2020;16(10):e1009100. DOI: https://doi.org/10.1371/journal.pgen.1009100Tian X, Liu Y, Yang J, et al. p.G970D is the most frequent CFTR mutation in Chinese patients with cystic fibrosis. Human Genome Variation. 2016;3(3):15063. DOI: https://doi.org/10.1038/hgv.2015.63Petrova NV, Marakhonov AV, Vasilyeva TA, et al. Comprehensive genotyping reveals novel CFTR variants in cystic fibrosis patients from the Russian Federation. Clinical Genetics. 2019;95(3):444-447. DOI: https://doi.org/10.1111/cge.13477Krasovsky SA, Sterinova MA, Voronkova AY, et al. editors. Register of patients with cystic fibrosis in the Russian Federation. 2021. Moscow: ID &quot;MEDPRAKTIKA-M&quot;; 2023. Russian.Kondratieva EI, Krasovsky SA, Voronkova AY, et al. editors. Register of patients with cystic fibrosis in the Russian Federation. 2015. Moscow: ID &quot;MEDPRAKTIKA-M&quot;; 2016. Russian.Krasovsky SA, Chernyak AV, Voronkova AY, et al. editors. Register of patients with cystic fibrosis in the Russian Federation. 2016. Moscow: ID &quot;MEDPRAKTIKA-M&quot;; 2018. Russian.Voronkova AY, Amelina EL, Kashirskaya NU, et al. editors. Register of patients with cystic fibrosis in the Russian Federation. 2017. Moscow: ID &quot;MEDPRAKTIKA-M&quot;; 2019. Russian.Amelina EL, Kashirskaya NU, Kondratieva YI, et al. editors. Register of patients with cystic fibrosis in the Russian Federation. 2018. Moscow: ID &quot;MEDPRAKTIKA-M&quot;; 2020. Russian.Kashirskaya NU, Kondratieva YI, Krasovsky SA, et al. editors. Register of patients with cystic fibrosis in the Russian Federation. 2019. Moscow: ID &quot;MEDPRAKTIKA-M&quot;; 2021. Russian.Kondratieva EI, Krasovsky SA, Starinova MA, et al. editors. Register of patients with cystic fibrosis in the Russian Federation. 2020. Moscow: ID &quot;MEDPRAKTIKA-M&quot;; 2022. Russian.Makaov AKh, Petrova NV, Timkovskaya EE, et al. Characteristics the spectrum of CFTR mutations in Karachay-Cherkessia. Modern Problems of Science and Education. 2016;2:28. Russian.Mazharov VN, Klimov LYa, Enina EA, et al. editors. Register of patients with cystic fibrosis of the North Caucasus Federal District of the Russian Federation. 2020. Stavropol: Izd-vo StGMU; 2022. Russian.Kondratyeva EI, Voronkova AYu, Kashirskaya NYu, et al. Russian registry of patients with cystic fibrosis: lessons and perspectives. Pulmonologiya. 2023;33(2):171-181. Russian. DOI: https://doi.org/10.18093/0869-0189-2023-33-2-171-181Tkemaladze T, Kvaratskhelia E, Ghughunishvili M, et al. Additional evidence on the phenotype produced by combination of&nbsp;CFTR&nbsp;1677delTA alleles and their relevance in causing CFTR-related disease. SAGE Open Medical Case Reports. 2023;11:1-4. DOI: https://doi.org/10.1177/2050313X231177163Clinical and Functional Translation of CFTR [Internet] [cited 2023 Nov 27]. Available from: http://cftr2.orgKondratyeva EI, Sherman VD, Amelina EL, et al. The clinical and genetic characteristics and outcomes of meconium ileus in cystic fibrosis. Russian Bulletin of Perinatology and Pediatrics. 2016;61(6):77-81. Russian. DOI: https://doi.org/10.21508/1027-4065-2016-61-6-77-81Aziz AD, Siddiqui F, Abbasi Q, et al. Characteristics of electrolyte imbalance and pseudo-bartter syndrome in hospitalized cystic fibrosis children and adolescents. Journal of Cystic Fibrosis. 2022;21(3):514-518. DOI: https://doi.org/10.1016/j.jcf.2021.09.013Choi N, Kang HG. Bartter Syndrome: Perspectives of a Pediatric Nephrologist. Electrolyte and Blood Pressure. 2022;20(2):49-56. DOI: https://doi.org/10.5049/EBP.2022.20.2.49Mantoo MR, Kabra M, Kabra SK. Cystic Fibrosis Presenting as Pseudo-Bartter Syndrome: An Important Diagnosis that is Missed! Indian Journal of Pediatrics. 2020;87(9):726-732. DOI: https://doi.org/10.1007/s12098-020-03342-8Kessler WR, Andersen DH. Heat prostration in fibrocystic disease of the pancreas and other conditions. Pediatrics. 1951;8(5):648-656. DOI: https://doi.org/10.1542/peds.8.5.648Sepe A, Romano C, Landi I, et al. Pseudo-Bartter syndrome in infant with cystic fibrosis screen positive, inconclusive diagnosis: A case report. Clinical Case Reports. 2023;11(11):e8046. DOI: https://doi.org/10.1002/ccr3.8046Sirhan AM, Kalinin M, Cohen L, et al. Uncommon Presentation of Cystic Fibrosis: A Case Report and Literature Review. Cureus. 2023;15(9):e45186. DOI: https://doi.org/10.7759/cureus.45186Petrova NV, Kashirskaya NYu, Kondratyeva EI, et al. The features of spectrum and frequency of CFTR gene mutations in populations of southern Russia and Northern Caucasus. Medical News of North Caucasus. 2020;15(2):174-178. Russian. DOI: https://doi.org/10.14300/mnnc.2020.15042